EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication

Sergio Ortega Del Campo iD, Gregorio Joaquín Fernández Ballester iD, Clara Blanes Mira iD, Víctor Guirado Osorio, Luis Díaz Martínez iD, Ana Isabel de Ávila iD, María Eugenia Soria iD, Brenda Martínez-González iD, Francisco José Villena González iD, Josefa Gómez-Maldonado iD, María Isabel Viciana Ramos, Encarnación Clavijo Frutos iD und 7 weitere

Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)

DOI: 10.1128/aac.01885-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Sergio Ortega Del Campo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Área de Genética, Facultad de Ciencias, Campus de Teatinos, Universidad de Málaga, Málaga, Spain. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Virus Replication, Peptides. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Ramón Areces, Universidad de Málaga, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limited durability of vaccine protection and the rapid emergence of SARS-CoV-2 variants highlight the need for antiviral strategies that extend beyond vaccination and conventional small-molecule inhibitors. Here, we explored a dual approach combining structure-guided peptides predicted to interfere with the viral replication complex with lethal mutagenesis to limit SARS-CoV-2 replication. Using the crystallographic interfaces of nsp10 with nsp14 and nsp16, we designed short inhibitory peptides predicted to interact with the viral proofreading and RNA-capping machinery. In parallel, the mutagenic analog 5-fluorouracil was evaluated to determine its effect on SARS-CoV-2 in Vero E6 cells. Peptides P1 and P6 exhibited potent antiviral activity with minimal cytotoxicity, whereas 5-FU reduced specific infectivity without impairing genome replication. Combined treatment with 5-FU and peptide P1 resulted in >10 4 -fold reduction in infectious virus, achieving near-complete loss of infectivity at non-cytotoxic concentrations. Next-generation sequencing revealed that dual treatment increased mutation frequency, altered mutant spectra, and decreased genome stability, consistent with progression toward error catastrophe. Principal component analysis confirmed that combined treatment generated mutant spectra distinct from either monotherapy. These findings are consistent with a dual antiviral strategy in which structure-guided peptides designed to interact with components of the SARS-CoV-2 replication complex act in combination with lethal mutagenesis to produce a synergistic interaction between these two complementary processes. This integrated approach suggests a potential broad-spectrum antiviral strategy with applicability to other coronaviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2Virus ReplicationPeptidesFluorouracilAnimalsVero CellsChlorocebus aethiopsViral Nonstructural ProteinsHumansDrug SynergismMutagenesisCOVID-19 Drug TreatmentExoribonucleases

Stichwörter der Autor:innen

5-fluorouracilExoN activityMTase activitySARS-CoV-2drug combinationlethal mutagenesismutant spectransp10peptide designsynergism

Substanzen

Antiviral AgentsPeptidesFluorouracilViral Nonstructural ProteinsNSP14 protein, SARS-CoV-2Exoribonucleases

Autor:innen und Institutionen

  • Área de Genética, Facultad de Ciencias, Campus de Teatinos, Universidad de Málaga, Málaga, Spain.
  • Instituto de Investigación en Biotecnología y Salud (IDiBE), Universidad Miguel Hernández, Elche, Spain.
  • Department of Public Health, History of Science and Gynecology, Universidad Miguel Hernández, Sant Joan d'Alacant, Spain.
  • Centro de Supercomputación y Bioinnovación (SCBI), Universidad de Málaga, Málaga, Spain.
  • Centro de Biología Molecular Severo Ochoa (CBM), (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid) (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain.
  • Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.

ORCID-Profile: Sergio Ortega Del Campo, Gregorio Joaquín Fernández Ballester, Clara Blanes Mira, Luis Díaz Martínez, Ana Isabel de Ávila, María Eugenia Soria, Brenda Martínez-González, Francisco José Villena González, Josefa Gómez-Maldonado, Encarnación Clavijo Frutos, Ugo Bastolla, Celia Perales, Esteban Domingo, Enrique Viguera, Ana María Fernández Escamilla, Ana Grande Pérez

Förderung

  • Fundación Ramón Areces
  • Universidad de Málaga
  • Ministerio de Ciencia, Innovación y Universidades
  • Generalitat Valenciana
  • Junta de Andalucía
  • Ministerio de Universidades (MU)
  • Spanish Agency of Research and FEDER
  • Fundacion Martin Varona

Zitieren

APA

Ortega Del Campo, S., Fernández Ballester, G. J., Blanes Mira, C., Guirado Osorio, V., Díaz Martínez, L., de Ávila, A. I., Soria, M. E., Martínez-González, B., Villena González, F. J., Gómez-Maldonado, J., Viciana Ramos, M. I., Clavijo Frutos, E., Santos González, J. L., Bastolla, U., Perales, C., Domingo, E., Viguera, E., Fernández Escamilla, A. M., & Grande Pérez, A. (2026). Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.01885-25

Vancouver

Ortega Del Campo S, Fernández Ballester GJ, Blanes Mira C, Guirado Osorio V, Díaz Martínez L, de Ávila AI, et al. Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.01885-25

BibTeX
@article{OrtegaDelCampo2026,
  author = {Ortega Del Campo, Sergio and Fernández Ballester, Gregorio Joaquín and Blanes Mira, Clara and Guirado Osorio, Víctor and Díaz Martínez, Luis and de Ávila, Ana Isabel and Soria, María Eugenia and Martínez-González, Brenda and Villena González, Francisco José and Gómez-Maldonado, Josefa and Viciana Ramos, María Isabel and Clavijo Frutos, Encarnación and Santos González, Jesús L and Bastolla, Ugo and Perales, Celia and Domingo, Esteban and Viguera, Enrique and Fernández Escamilla, Ana María and Grande Pérez, Ana},
  title = {Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {6},
  doi = {10.1128/aac.01885-25}
}
Kostenlos starten →